Kang Xiao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Kang Xiao has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Birui Jin
School of Materials and Chemical Engineering, Xi'an Technological University, Xi'an, P. R. China
1 shared publication- Cao Chen
National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, NHC Key Laboratory for Medical Virology and Viral Diseases, Beijing Key Laboratory of Viral Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention & Chinese Academy of Preventive Medicine, Beijing 102206, China
1 shared publication - Dan Bai
Northwestern Polytechnical University
1 shared publication - Dong-Hua Zhou
National Key-Laboratory of Intelligent Tracking and Forecasting for Infectious Disease , NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention (Chinese Academy of Preventive Medicine), Chinese Centre for Disease Control and Prevention, Beijing 102206
1 shared publication - Dong-Lin Liang
National Key-Laboratory of Intelligent Tracking and Forecasting for Infectious Disease , NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention (Chinese Academy of Preventive Medicine), Chinese Centre for Disease Control and Prevention, Beijing 102206
1 shared publication - Fanpu Ji
Department of Hepatology The Second Affiliated Hospital of Xi'an Jiaotong University Xi'an China
1 shared publication
Latest Publications
- Open Access
- 19 August 2026
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
Estimating the Penetrance of PRNP Mutations in Chinese Prion Disease Patients based on the Genome Databases
Genetic prion diseases (gPrDs) are directly caused by mutations in the prion protein gene (PRNP). Although several mutations have been strongly linked to disease manifestation, the penetrance of many variants remains uncertain. This study aimed to clarify the penetrance of PRNP variants by analyzing data from the Chinese surveillance system and comparing them to large genome databases representing East Asian and global genetic backgrounds. Our analysis included 301 gPrD cases with PRNP point mutations alongside 96,462 individuals of East Asian genetic descent and 784,714 from a global cohort. Notably, the D178N, E200K, and P102L mutations exhibited high penetrance irrespective of genetic background, underscoring their pathogenic potential. T188K, the most frequent variant in Chinese gPrD cases, also showed high penetrance across all cohorts despite its regional specificity. Conversely, estimates of E196A penetrance were low, particularly in the Chinese and East Asian cohorts. Variants such as S97N and R148H showed extremely low penetrance across all cohorts, while V180I and V210I displayed distinct regional and ethnic variations in both prevalence and penetrance. However, the penetrance of rare mutations could not be reliably estimated due to insufficient case numbers. These insights highlight the complex interplay between genetic variation and disease risk, necessitating further investigation into the genetic epidemiology of gPrD.
- 19 August 2026
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
Open AccessEstimating the Penetrance of PRNP Mutations in Chinese Prion Disease Patients based on the Genome Databases
Genetic prion diseases (gPrDs) are directly caused by mutations in the prion protein gene (PRNP). Although several mutations have been strongly linked to disease manifestation, the penetrance of many variants remains uncertain. This study aimed to clarify the penetrance of PRNP variants by analyzing data from the Chinese surveillance system and comparing them to large genome databases representing East Asian and global genetic backgrounds. Our analysis included 301 gPrD cases with PRNP point mutations alongside 96,462 individuals of East Asian genetic descent and 784,714 from a global cohort. Notably, the D178N, E200K, and P102L mutations exhibited high penetrance irrespective of genetic background, underscoring their pathogenic potential. T188K, the most frequent variant in Chinese gPrD cases, also showed high penetrance across all cohorts despite its regional specificity. Conversely, estimates of E196A penetrance were low, particularly in the Chinese and East Asian cohorts. Variants such as S97N and R148H showed extremely low penetrance across all cohorts, while V180I and V210I displayed distinct regional and ethnic variations in both prevalence and penetrance. However, the penetrance of rare mutations could not be reliably estimated due to insufficient case numbers. These insights highlight the complex interplay between genetic variation and disease risk, necessitating further investigation into the genetic epidemiology of gPrD.
- 8 July 2019
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 116 (10) , 2764-2777
Paper‐based point‐of‐care test with xeno nucleic acid probes
Bridging the unmet need of efficient point‐of‐care testing (POCT) in biomedical engineering research and practice with the emerging development in artificial synthetic xeno nucleic acids (XNAs), this review summarized the recent development in paper‐based POCT using XNAs as sensing probes. Alongside the signal transducing mode and immobilization methods of XNA probes, a detailed evaluation of probe performance was disclosed. With these new aspects, both researchers in synthetic chemistry / biomedical engineering and physicians in clinical practice could gain new insights in designing, manufacturing and choosing suitable reagents and techniques for POCT.
- 8 July 2019
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 116 (10) , 2764-2777
Paper‐based point‐of‐care test with xeno nucleic acid probes
Bridging the unmet need of efficient point‐of‐care testing (POCT) in biomedical engineering research and practice with the emerging development in artificial synthetic xeno nucleic acids (XNAs), this review summarized the recent development in paper‐based POCT using XNAs as sensing probes. Alongside the signal transducing mode and immobilization methods of XNA probes, a detailed evaluation of probe performance was disclosed. With these new aspects, both researchers in synthetic chemistry / biomedical engineering and physicians in clinical practice could gain new insights in designing, manufacturing and choosing suitable reagents and techniques for POCT.